Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Pharmacotherapy of Nicotine Dependence

  • Chapter
Pharmacological Aspects of Drug Dependence

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 118))

Abstract

Several excellent narrative and meta-analytic reviews of different pharmacotherapies for smoking cessation have recently been published (GLASSMAN and COVEY 1990; GOLDSTEIN et al. 1991; GOURLAY and MCNEIL 1990; HUGHES 1993a; JARVIK and HENNINGFIELD 1988, 1993; JARVIK and SCHNEIDER 1992; LEE and D’ALONZO 1993; NUNN-THOMPSON and SIMON 1989; PRIGNOT 1989; SACHS 1991; SACHS et al. 1994; SACHS and LEISCHOW 1991a; SCHWARTZ 1987; US DEPARTMENT OF HEALTH AND HUMAN SERVICES 1988). The present review will differ somewhat from these in that it will focus on promising medications and areas of future research.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bachynsky N (1986) The use of anticholinergic drugs for smoking cessation: A pilot study. Int J Addict 21:789–805

    PubMed  CAS  Google Scholar 

  • Baillie A, Mattick RP, Hall W, Webster P (in press) Meta-analytic review of the efficacy of smoking cessation interventions. Drug Alcohol Rev

    Google Scholar 

  • Bazot M, Fabre JD, Ortolan JM, Schweitzer J (1982) An unanticipated effect of metronidazole. In: Molimard R. (ed) 1 journee de la dependence tabaqique. Biomedicale des Sainte-Peres, Paris, pp 113–122

    Google Scholar 

  • Belcher M, Jarvis MJ, Sutherland G (1989) Nicotine absorption and dependence in an over the counter aid to stopping smoking. Br Med J 298:570

    CAS  Google Scholar 

  • Benowitz NL (1988) Pharmacologic aspects of cigarette smoking and nicotine addiction. Engl J Med 319: 1318–1330

    CAS  Google Scholar 

  • Benowitz NL (1991) Nicotine replacement therapy during pregnancy. JAMA 266: 3174–3177

    PubMed  CAS  Google Scholar 

  • Benowitz NL (1993) Nicotine replacement therapy: what has been accomplished — can we do better? Drugs 2: 157–170

    Google Scholar 

  • Bourne SJ (1985) Treatment of cigarette smoking with short term high dosage corticotrophin therapy: preliminary communication. JR Soc Med 78: 649–650

    CAS  Google Scholar 

  • Bourne SJ (1991) Towards a neuro-endocrine explanation of tobacco addiction. J Smoking Relat Dis 2: 105–110

    Google Scholar 

  • Bowen DJ, Spring B, Fox E (1991) Tryptophan and high-carbohydrate diets as adjuncts to smoking cessation therapy. J Behav Med 14: 97–110

    PubMed  CAS  Google Scholar 

  • Breslau N, Kilbey MM, Andreski P (1991) Nicotine dependence, major depression, and anxiety in young adults. Arch Gen Psychiatr 48: 1069–1074

    PubMed  CAS  Google Scholar 

  • Breslau N, Kilbey MM, Andreski P (1992) Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults. Am J Psychiatry 149: 464–469

    PubMed  CAS  Google Scholar 

  • Cepeda-Benito A (1993) Meta-analytical review of the efficacy of nicotine chewing gum in smoking treatment programs. J Consult Clin Psychol 61: 822–830

    PubMed  CAS  Google Scholar 

  • Cinciripini PM, Lapitsky L, Seay S, Wallfisch A, Meyer WJ III, Van Vunakis H (1995) A placebo controlled evaluation of the effects of buspirone on smoking cessation: differences between high and low anxiety smokers. J Behav Med (in press)

    Google Scholar 

  • Clarke PBS (1991) Nicotinic receptor blockade therapy and smoking cessation. Br J Addict 86: 501–505

    PubMed  CAS  Google Scholar 

  • Clarke PBS (1992) Recent advances in understanding the actions of nicotine in the central nervous system. J Natl Cancer Inst Monogr 2: 229–238

    Google Scholar 

  • Coambs RB, Kozlowski LT, Ferrence RG (1989) The future of tobacco use and smoking research. In: Ney T, Gale A. (eds) Smoking and human behavior. Wiley, New York, pp 337–348

    Google Scholar 

  • Cohen S, Lichtenstein E, Prochaska JO, Rossi JS, Gritz ER, Carr CR, Orleans CT, Schoenbach VJ, Biener L, Abrams D, DeClemente C, Curry S, Marlatt GA, Cumming KM, Emont SL, Giovino G, Ossip-Klein D (1989) Debunking myths about self-quitting. Am Psychol 44: 1355–1365

    PubMed  CAS  Google Scholar 

  • Covey LS, Glassman AH (1991) A mete-analysis of double-blind placebo-controlled trials of clonidine for smoking cessation. Br J Addict 86: 991–998

    PubMed  CAS  Google Scholar 

  • Covey LS, Glassman AH, Stetner F (1990) Depression and depressive symptoms in smoking cessation. Compr Psychiatry 31: 350–354

    PubMed  CAS  Google Scholar 

  • Cummings SR, Hansen B, Richard RJ, Stein MJ, Coates TJ (1988) Internists and nicotine gum. JAMA 260: 1565–1569

    PubMed  CAS  Google Scholar 

  • Daughton DM, Heatley SA, Prendergast JJ, Causey D, Knowles M, Rolf CN, Cheney RA, Hattelid K, Thompson AB, Rennard SI (1991) Effect of transdermal nicotine delivery as an adjunct to low intervention smoking cessation therapy: a randomized placebo-controlled, double-blind study. Arch Intern Med 151: 749–752

    PubMed  CAS  Google Scholar 

  • Davison GC, Rosen RC (1972) Lobeline and reduction of cigarette smoking. Psychol Rep 31: 443–456

    PubMed  CAS  Google Scholar 

  • Department of Health and Human Services (1982) Smoking deterrent drug products for over-the-counter human use: establishment of a monograph. Federal register, Docket no. 81N-0027, pp 490–500

    Google Scholar 

  • Dow RJ, Fee WM (1984) Use of beta-blocking agents with group therapy in a smoking withdrawal clinic. J R Soc Med 77: 648–651

    PubMed  CAS  Google Scholar 

  • Edwards NB, Murphy JK, Downs AD, Ackerman BJ, Rosenthal TL (1988) Doxepin as an adjunct to smoking cessation: a double-blind pilot study. J Psychiatr 146: 373–376

    Google Scholar 

  • Fagerstrom K-O (1988) Efficacy of nicotine chewing gum: a review. In: Pomerleau OF, Pomerleau CS, Fagerstrom K-O, Henningfield JE, Hughes JR (eds) Nicotine replacement: a critical evaluation. Liss, New York, pp 109–128

    Google Scholar 

  • Fagerstrom K-O (1994) Combined use of nicotine replacement products. Health Values 18: 15–20

    Google Scholar 

  • Fagerstrom K-O, Melin B (1985) Nicotine chewing gum in smoking cessation: efficacy, nicotine dependence, therapy duration, and clinical recommendations. In: Grabowski J, Hall SM (eds) Pharmacological adjuncts in smoking cessation, National Institute on Drug Abuse monograph 53, Washington: DHHS publication no (ADM) 85-1553, pp 102–109

    Google Scholar 

  • Fagerstrom K-O, Schneider NG (1989) Measuring nicotine dependence: a review of the Fagerstrom tolerance questionnaire. J Behav Med 12: 159–182

    PubMed  CAS  Google Scholar 

  • Fagerstrom K-O, Lunell E, Molander L (1991) Continuous and intermittent transdermal delivery of nicotine: blockade of withdrawal symptoms and sideeffects. J Smoking Relat Dis 2: 173–180

    Google Scholar 

  • Fagerstrom K-O, Sawe U, Tonnesen P (1992) Therapeutic use of nicotine patches: efficacy and safety. J Smoking Relat Dis 3: 247–261

    Google Scholar 

  • Fagerstrom K-O, Schneider NG, Lunell E (1993) Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms. Psychopharmacology 111: 271–277

    PubMed  CAS  Google Scholar 

  • Farebrother MJB, Pearce SJ, Turner P, Appleton DR (1980) Propranolol and giving up smoking. Br J Dis Chest 74: 95–96

    PubMed  CAS  Google Scholar 

  • Ferry LH, Robbins AS, Scariati PD, Peters A (in press) Depression, craving and heavy smoking: a pilot trial using bupropion. Addictive Diseases

    Google Scholar 

  • Fiore MC, Novotny TE, Pierce JP, Giovino GA, Hatziandreu EJ, Newcomb PA, Surawicz TS, Davis RM (1990) Methods used to quit smoking in the United States. JAMA 263: 2760–2765

    PubMed  CAS  Google Scholar 

  • Fiore MC, Jorenby DE, Baker TB, Kenford SL (1992) Tobacco dependence and the nicotine patch: clinical guidelines for effective use. JAMA 268: 2687–2694

    PubMed  CAS  Google Scholar 

  • Fiore MC, Smith SS, Jorenby DE, Baker TB (1994) The effectiveness of the nicotine patch for smoking cessation. JAMA 271: 1940–1947

    PubMed  CAS  Google Scholar 

  • Fixx AJ, Daughton D, Kass I, Smith JL, Wickiser A, Golden CJ (1983) Urinary alkanization and smoking cessation. J Clin Psychol 39: 618–623

    Google Scholar 

  • Foulds J (1993) Does nicotine replacement therapy work? Addiction 88: 1473–1478

    PubMed  CAS  Google Scholar 

  • Foulds J, Stapleton J, Feyerabend C, Vesey C, Jarvis M, Russell MAH (1992) Effect of transdermal nicotine patches on cigarette smoking: a double-blind crossover study. Psychopharmacology 106:421–427

    PubMed  CAS  Google Scholar 

  • Fredrickson PA, Lee GM, Wingender LA, Croghan IT, Offord KP, Hurt RD (1993) Safety and tolerance of high dose transdermal nicotine therapy in light (LS) and heavy (HS) smokers. J Addict Dis 12: 177

    Google Scholar 

  • Gawin FH, Compton M, Byck R (1989) Buspirone reduces smoking. Arch Gen Psychiatry 46: 288–289

    PubMed  CAS  Google Scholar 

  • Gittelman R, Mannuzza S, Shenker R, Bonagura N (1985) Hyperactive boys almost grown up, I: psychiatric status. Arch Gen Psychiatry 42: 937–947

    PubMed  CAS  Google Scholar 

  • Glass RM (1990) Blue mood, blackened lungs: depression and smoking. JAMA 264: 1583–1584

    PubMed  CAS  Google Scholar 

  • Glassman AH (1993) Cigarette smoking: implications for psychiatric illness. Am J Psychiatry 150: 546–553

    PubMed  CAS  Google Scholar 

  • Glassman AH, Covey LS (1990) Future trends in the pharmacological treatment of smoking cessation. Drugs 40: 1–5

    PubMed  CAS  Google Scholar 

  • Glassman AH, Jackson WK, Walsh BT, Roose SP (1985) Cigarette craving, smoking withdrawal, and clonidine. Science 226: 864–866

    Google Scholar 

  • Glassman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, Johnson J (1990) Smoking, smoking cessation, and major depression. JAMA 264: 1546–1549

    PubMed  CAS  Google Scholar 

  • Glassman AH, Covey LS, Dalack GW, Stetner F, Rivelli SK, Fleiss J, Cooper TB (1993) Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clin Pharmacol Ther 54: 670–679

    PubMed  CAS  Google Scholar 

  • Goldstein MG, Niaura R, Follick MJ, Abrams DB (1989) Effects of behavioral skills training and schedule of nicotine gum administration on smoking cessation. Am J Psychiatry 146: 56–60

    PubMed  CAS  Google Scholar 

  • Goldstein MG, Niaura R, Abrams DB (1991) Pharmacological and behavioral treatment of nicotine dependence: nicotine as a drug of abuse. In: Stoudemire A, Fogel BS (eds) Medical-psychiatric practice. American Psychiatric Press, Washington DC, pp 541–596

    Google Scholar 

  • Gora ML (1993) Nicotine transdermal systems. Ann Pharmacother 27: 742–750

    PubMed  CAS  Google Scholar 

  • Gorelick DA, Rose JE, Jarvik ME (1989) Effect of naloxone on cigarette smoking. J Subst Abuse 1: 153–159

    CAS  Google Scholar 

  • Gourlay S, Forbes A, Marriner T, Kutin J, McNeil J (1994) A placebo-controlled study of three clonidine doses for smoking cessation. Clin Pharmacol Ther 55: 64–69

    PubMed  CAS  Google Scholar 

  • Gourlay SG, McNeil JJ (1990) Antismoking products. Med J Aust 153:699–707

    PubMed  CAS  Google Scholar 

  • Grunberg NE, Kozlowski LT (1986) Alkaline therapy as an adjunct to smoking cessation programs. Int J Biosocial Res 8: 43–52

    Google Scholar 

  • Hajek P, Jackson P, Belcher M (1988) Long-term use of nicotine chewing gum. JAMA 260: 1593–1596

    PubMed  CAS  Google Scholar 

  • Hall SM, Tunstall CD, Vila KL, Duffy J (1992) Weight gain prevention and smoking cessation: cautionary findings. Am J Publ Health 82: 799–803

    CAS  Google Scholar 

  • Hall SM, Munoz RF, Reus VI, Sees KL (1993) Nicotine, negative affect, and depression. J Consult Clin Psychol 61: 761–767

    PubMed  CAS  Google Scholar 

  • Hall SM, Munoz RF, Reus VI (1994) Cognitive-behavioral intervention increases abstinence rates for depressive history smokers. J Consult Clin Psychol 62:141–146

    PubMed  CAS  Google Scholar 

  • Hartsough CS, Lambert NM (1987) Pattern and progression of drug use among hyperactives and controls: a prospective short-term longitudinal study. J Child Psychiatry 28: 543–553

    CAS  Google Scholar 

  • Hatsukami DK, Huber M, Callies A, Skoog K (1993) Physical dependence on nicotine gum: effect of duration of use. Psychopharmacology 111: 449–456

    PubMed  CAS  Google Scholar 

  • Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom K-O (1991) The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 86: 1119–1127

    PubMed  CAS  Google Scholar 

  • Henningfield JE, Stitzer ML (1991) New developments in nicotine-delivery systems. Communications, Ossining

    Google Scholar 

  • Henningfield JE, Chait LD, Griffiths RR (1983a) Cigarette smoking and subjective responsive in alcoholics: effects of pentobarbital. Clin Pharmacol Ther 33: 806–812

    CAS  Google Scholar 

  • Henningfield JE, Miyasato K, Johnson RE, Jasinski DR (1983b) Rapid physiologic effects of nicotine in humans and selective blockade of behavioral effects by mecamylamine. In: Harris LS (ed) Problems of drug dependence, 1982, NIDA research monograph. US Government Printing Office, Washington DC, pp 259–265

    Google Scholar 

  • Henningfield JE, London ED, Benowitz NL (1990) Arterial-venous differences in plasma concentrations of nicotine after cigarette smoking. JAMA 263: 2049–2050

    PubMed  CAS  Google Scholar 

  • Henningfield JE, Stapleton JM, Benowitz NL, Grayson RF, London ED (1993) Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend 33: 23–29

    PubMed  CAS  Google Scholar 

  • Hilleman DE, Mohiuddin SM, Delcore MG (1994) Comparison of fixed-dose transdermal nicotine, tapered-dose transdermal nicotine and buspirone in smoking cessation. J Clin Pharmacol 34: 222–224

    PubMed  CAS  Google Scholar 

  • Hughes JR (1986) Problems of nicotine gum. In: Ockene JK (ed) Pharmacologic treatment of tobacco dependence: proceedings of the world congress, 3–5 Nov 1985, Institute for the Study of Smoking Behavior and Policy, Cambridge, pp 141–147

    Google Scholar 

  • Hughes JR (1988) Clonidine, depression and smoking cessation. JAMA 254: 2901–2902

    Google Scholar 

  • Hughes JR (1991) Combined psychological and nicotine gum treatment for smoking: a critical review. J Subst Abuse 3: 337–350

    PubMed  CAS  Google Scholar 

  • Hughes JR (1992) Tobacco withdrawal in self-quitters. J Consult Clin Psychol 60: 689–697

    PubMed  CAS  Google Scholar 

  • Hughes JR (1993a) Pharmacotherapy for smoking cessation: Unvalidated assumptions and anomalies, and suggestions for further research. J Consult Clin Psychol 61: 751–760

    CAS  Google Scholar 

  • Hughes JR (1993b) Treatment of smoking cessation in smokers with past alcohol/ drug problems. J Subst Abuse Tx 10: 181–187

    CAS  Google Scholar 

  • Hughes JR (1993c) Possible effects of smoke-free inpatient units on psychiatric diagnosis and treatment. J Clin Psychiatr 54: 109–114

    CAS  Google Scholar 

  • Hughes JR (1993d) Risk/benefit of nicotine replacement in smoking cessation. Drug Safety 8: 49–56

    CAS  Google Scholar 

  • Hughes JR (1994) Behavioral support programs for smoking cessation. Mod Med 62: 22–26

    Google Scholar 

  • Hughes JR (in press) Combining behavoiral therapy and pharmacotherapy for smoking cessation: an update. In: Blaine J, Onken L (eds) Integrating behavoir therapies with medication in the treatment of drug dependence, NIDA research monograph. US Goverment Printing Office, Washington DC (in press)

    Google Scholar 

  • Hughes JR, Glaser M (1993) Transdermal nicotine for smoking cessation. Health Values 17: 24–31

    Google Scholar 

  • Hughes JR, Hatsukami DK (1992) The nicotine withdrawal syndrome: a brief review and update. Int J Smoking Cessation 1: 21–26

    Google Scholar 

  • Hughes JR, Gust SW, Keenan RM, Fenwick JW, Healy ML (1989) Nicotine vs placebo gum in general practice. JAMA 261: 1300–1305

    PubMed  CAS  Google Scholar 

  • Hughes JR, Higgins ST, Hatsukami DK (1990) Effects of abstinence from tobacco: a critical review. In: Kozlowski LT, Annis H, Cappell HD, Glaser F, Goodstadt M, Israel Y, Kalant H, Sellers EM, Vingilis J (eds) Research advances in alcohol and drug problems, vol 10. Plenum, New York, pp 317–398

    Google Scholar 

  • Hughes JR, Gust SW, Keenan RM, Skoog K, Fenwick JW, Higgins ST (1991) Longterm use of nicotine versus placebo gum. Arch Intern Med 151: 1993–1998

    PubMed  CAS  Google Scholar 

  • Hughes JR, Gulliver SB, Fenwick JW, Cruser K, Valliere WA, Pepper SL, Shea PJ, Solomon LJ (1992) Smoking cessation among self-quitters. Health Psychol 11: 331–334

    PubMed  CAS  Google Scholar 

  • Hurt RD, Dale LC, Fredrickson PA, Caldwell CC, Lee GA, Offord KP, Lauger GG, Marusic Z, Neese LW, Lundberg TG (1994) Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. JAMA 271: 595–600

    PubMed  CAS  Google Scholar 

  • Hymowitz N, Feuerman M, Hollander M, Frances RJ (1993) Smoking deterrence using silver acetate. Hosp Commun Psychiatr 44: 113–117

    CAS  Google Scholar 

  • Jacobs MA, Spiker AZ, Norman MM, Wohlberg GW, Knapp PH (1971) Interaction of personality and treatment conditions associated with success in a smoking control program. Psychosom Med 6: 545–556

    Google Scholar 

  • Jamrozik K, Vessey M, Fowler G, Wald N, Parker G, VanVunakis H (1984) Controlled trial of three different antismoking interventions in general practice. Br Med J 288: 1499–1503

    CAS  Google Scholar 

  • Jarvik ME, Henningfield JE (1988) Pharmacological treatment of tobacco dependence. Pharmacol Biochem Behav 30: 279–294

    PubMed  CAS  Google Scholar 

  • Jarvik ME, Henningfield JE (1993) Pharmacological adjuncts for the treatment of tobacco dependence. In: Orleans CT, Slade J (eds) Nicotine addiction: principles and management. Oxford University Press, New York, pp 245–261

    Google Scholar 

  • Jarvik ME, Schneider NG (1992) Nicotine. In: Lowinson JH, Ruiz P, Millman RB, Langrod JG (eds) Substance abuse: a comprehensive textbook. Williams and Wilkins, Baltimore, pp 334–356

    Google Scholar 

  • Jarvik ME, Glick SD, Nakamura RK (1970) Inhibition of cigarette smoking by orally administered nicotine. Clin Pharmacol Ther 11: 574–576

    CAS  Google Scholar 

  • Jarvis MJ, Hajek P, Russell MAH, West RJ (1987) Nasal nicotine solution as an aid to cigarette withdrawal: a pilot clinical trial. Br J Addict 82: 983–988

    PubMed  CAS  Google Scholar 

  • Jensen EJ, Schmidt E, Pedersen B, Dahl R (1991) Effect on smoking cessation of silver acetate, nicotine and ordinary chewing gum. Psychopharmacology 104: 470–474

    PubMed  CAS  Google Scholar 

  • Kamarck TW, Lichtenstein E (1985) Current trends in clinic-based smoking control. Ann Behav Med 7: 19–23

    Google Scholar 

  • Kandel DB, Davies M (1986) Adult sequelae of adolescent depressive symptoms. Arch Gen Psychiatry 43: 255–262

    PubMed  CAS  Google Scholar 

  • Karras A (1982) Neurotransmitter and neuropeptide correlates of cigarette smoking. In: Essman WR, Valvelli L (eds) Neuropharmacology: clinical applications. New York: Springer, Berlin Heidelberg New York, pp 41–66

    Google Scholar 

  • Karras A, Kane J (1980) Naloxone reduces cigarette smoking. Life Sci 27: 1541–1545

    PubMed  CAS  Google Scholar 

  • Killen JD, Fortmann SP, Newman B, Varady A (1990) Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. J Consult Clin Psychol 58: 85–92

    PubMed  CAS  Google Scholar 

  • Klesges RC, Meyers AW, LaVasque ME (1989) Smoking, body weight and their effects on smoking behavior: a comprehensive review of the literature. Psychol Bull 106: 204–230

    PubMed  CAS  Google Scholar 

  • Klesges RC, Klesges LM, Meyers AW, Klein ML, Isbell T (1990) The effects of phenylpropanolamine on dietary intake, physical activity, and body weight after smoking cessation. Clin Pharmacol Ther 47: 747–754

    PubMed  CAS  Google Scholar 

  • Kornitzer M, Kittel F, Dramaix M, Bourdoux P (1987) A double blind study of 2 mg versus 4mg nicotine gum in an industrial setting. J Psychosom Res 31:171–176 Kozlowski LT (1984) Pharmacological approaches to smoking modification. In: Matarazzo JD, Weiss SM, Herd JA, Miller NE (eds) Behavioral health: a handbook of health enhancement and disease prevention. Wiley, New York, (1987)

    Google Scholar 

  • Kozlowski LT (1984) Pharmacological approaches to smoking modification. In: Matarazzo JD, Weiss SM, Herd JA, Miller NE (eds) Behavoiral health: a handbook of health enchancement and disease prevention. Wiley, New York, (1987)

    Google Scholar 

  • Lam WL, Sze PC, Sacks HS, Chalmer TC (1987) Meta-analysis of randomized controlled trials of nicotine chewing gum. Lancet 2: 27–29

    PubMed  CAS  Google Scholar 

  • Lee EW, D’Alonzo GE (1993) Cigarette smoking, nicotine addiction and its pharmacologic treatment. Arch Intern Med 153: 34–48

    PubMed  CAS  Google Scholar 

  • Leischow SJ, Sachs DPL, Hansen MD, Bostrom, AG (1992) Effects of different nicotine replacement doses on weight gain after smoking cessation. Arch Fam Med 1: 233–237

    PubMed  CAS  Google Scholar 

  • Leischow SJ, Valente SN, Hill AL, Otte PS, Aickin M, Kligman EW, Nicotine patch and gum: withdrawal symptoms, side effects, and medication preference. In: Harris LS (ed) Problems of drug dependence 1994, NIDA research monograph. US Goverment Printing Office, Washington DC (in press)

    Google Scholar 

  • Levin ED (1992) Nicotinic systems and cognitive function. Psychopharmacology 108: 417–431

    PubMed  CAS  Google Scholar 

  • Levin ED, Westman EC, Stein RM, Carnahan E, Sanchez M, Herman S, Behm FM, Rose JE (1994) Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms and attenuates rewarding effects of smoking. J Clin Psychopharm 14:41–49

    CAS  Google Scholar 

  • Lichtenstein E, Glasgow RE (1992) Smoking cessation: what have we learned over the past decade? J Consult Clin Psychol 60: 518–527

    PubMed  CAS  Google Scholar 

  • Lichtenstein E, Hollis JF (1992) Patient referral to a smoking cessation program: who follows through? J Fam Pract 34: 739–744

    PubMed  CAS  Google Scholar 

  • Low RB, Jones M, Carter B, Cadoret RJ (1984) The effect of d-amphetamine and ephedrine on smoking attitude and behavior. Addict Behav 9: 335–345

    PubMed  CAS  Google Scholar 

  • McElhaney JL (1989) Repository corticotropin injection as an adjunct to smoking cessation during the initial nicotine withdrawal period: results from a family practice clinic. Clin Ther 11: 854–861

    PubMed  CAS  Google Scholar 

  • Meier-Lammermann E, Meyer M, Boleskei PL (1990) Differences between transdermal nicotine application and nicotine chewing gum in combination with behavioural group therapy in smoking cessation.Eur Respir J 3 [Suppl 10]: 1685

    Google Scholar 

  • Mello NK, Mendelson JH, Sellers ML, Kuehnle JC (1980) Effects of heroin self-administration on cigarette smoking. Psychopharmacology 67: 45–52

    PubMed  CAS  Google Scholar 

  • Miller MM (1941) Benzadrine sulphate in the treatment of nicotinism. Med Rec 153: 137–138

    Google Scholar 

  • Minneker E, Buchkremer G, Block M (1989) The effect of different dosages of a transdermal nicotine substitution system on the success rate of smoking cessation therapy. Methods Find Exp Clin Pharmacol 11: 219–222

    PubMed  CAS  Google Scholar 

  • Nemeth-Coslett R, Griffiths RR (1986) Naloxone does not affect cigarette smoking. Psychopharmacology 89:261–264

    PubMed  CAS  Google Scholar 

  • Nemeth-Coslett R, Henningfield JE, O’Keefe MK, Griffiths RR (1986) Effects of mecamylamine on human cigarette smoking and subjective ratings. Psychopharmacology 88:420–425

    PubMed  CAS  Google Scholar 

  • Newhouse P, Hughes JR (1991) The role of nicotine and nicotine mechanisms in neuropsychiatric disease. Br J Addict 86: 521–526

    PubMed  CAS  Google Scholar 

  • Niaura R, Goldstein MG, Brown R, Murphy J, Abrams, D (1993) A double-blind randomized dose-response trial of transdermal clonidine for smoking cessation. Presented at Society of Behavioral Medicine Meeting, San Francisco, March 1993

    Google Scholar 

  • Nunn-Thompson CL, Simon PA (1989) Pharmacotherapy for smoking cessation. Clin Pharm 8: 710–720

    PubMed  CAS  Google Scholar 

  • O’Malley SS, Jaffe AJ, Chang G, Schottenfield RS, Meyer RE, Rounsaville B (1992) Naltrexone and coping skills therapy for alcohol dependence. Arch Gen Psychiatry 49:881–887

    PubMed  Google Scholar 

  • Palmer KJ, Faulds D (1992) Transdermal nicotine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as an aid to smoking cessation. Drugs 44: 498–529

    PubMed  CAS  Google Scholar 

  • Paoletti P, Fornai E, Maggiorelli F, Corlando A, Puntoni R, Molesti D, Carrozzi L, Viegi G, Martinelli M, Celiano F, Gustavsson G, Sawe U (1993) A double-blind clinical trial on smoking cessation using different doses of 16-hours transdermal nicotine patches after cotinine plasma values stratification. Chest 146: A806

    Google Scholar 

  • Perkins KA, Grobe JE, Stiller RL, Fonte C, Goettler JE (1992) Nasal spray nicotine replacement suppresses cigarette smoking desire and dehavior. Clin Pharmacol Ther 52: 627–634

    PubMed  CAS  Google Scholar 

  • Pickworth WB, Herning RI, Henningfield JE (1988) Mecamylamine reduces some EEG effects of nicotine chewing gum in humans. Pharmacol Biochem Behav 30: 149–153

    PubMed  CAS  Google Scholar 

  • Pierce JP, Fiore MC, Novotny TE, Hatziandreu EJ, Davis RM (1989) Trends in cigarette smoking in the United States. Educational differences are increasing. JAMA 261: 56–60

    PubMed  CAS  Google Scholar 

  • Pinney JM (1991) Factors affecting availability of treatment. In: Henningfield, JE, Stitzer, ML (eds) New developments in nicotine-delivery systems. Cortlandt Communications, Ossining, pp 79–88

    Google Scholar 

  • Pirie PL, McBride CM, Hellerstedt W, Jeffery RW, Hatsukami DK, Allen S, Lando H (1992) Smoking cessation in women concerned about weight. Am J Public Health 82: 1238–1243

    PubMed  CAS  Google Scholar 

  • Po ALW (1993) Transdermal nicotine in smoking cessation. Eur J Clin Pharmacol 45: 519–528

    Google Scholar 

  • Pomerleau CS, Pomerleau OF, Majchrzak MJ (1987) Mecamylamine pretreatment increases subsequent nicotine self-administration as indicated by changes in plasma nicotine level. Psychopharmacology 91: 391–393

    PubMed  CAS  Google Scholar 

  • Pomerleau O, Pomerleau C, Fagerstrom K-O, Henningfield JE, Hughes JR (1988) Nicotine replacement: a critical evaluation. Haworth, New York

    Google Scholar 

  • Pomerleau OF, Pomerleau CF (1984) Neuroregulators and the reinforcement of smoking: towards a biobehavioral explanation. Neurosci Biobehav Rev 8: 503–513

    PubMed  CAS  Google Scholar 

  • Pomerleau OF, Flessland KA, Pomerleau CS, Hariharan M (1992) Controlled dosing of nicotine via an Intranasal Nicotine Aerosol Delivery Device (INADD). Psychopharmacology 15: 519–526

    Google Scholar 

  • Prignot J (1989) Pharmacological approach to smoking cessation. Eur Respir J 2: 550–560

    PubMed  CAS  Google Scholar 

  • Prochazka AV, Petty TL, Nett L, Silvers GW, Sachs DPL, Rennard SI, Daughton DM, Grimm RH Jr, Heim C (1992) Transdermal clonidine reduced some withdrawal symptoms but did not increase smoking cessation. Arch Intern Med 152: 2065–2069

    PubMed  CAS  Google Scholar 

  • Puska P, Vartiainen E, Korhone H, Urjanheimo EL, Gustavsson G (1994) Combining patch and gum in nicotine replacement therapy: results of a double-blind study in North Karelia. Presented at Society of Behavioral Medicine Meeting, Boston, April 1994

    Google Scholar 

  • Rennard S, Daughton D, Fortmann S, Killen J, Petty E et al. (1991) Transdermal nicotine enhances smoking cessation in coronary artery disease patients. Chest 100: 5S (abstract)

    Google Scholar 

  • Robinson MD, Smith WA, Cederstrom EA, Sutherland DE (1991) Buspirone effect on tobacco withdrawal symptoms: a pilot study. J Am Board Fam Pract 4:89–94

    PubMed  CAS  Google Scholar 

  • Robinson MD, Anastasio GD, Little JM, Sigmon JL, Menscer D, Pettice, YJ, Norton HJ (1993) Ritalin for tobacco withdrawal: a pilot study. J Addict Dis 12:178

    Google Scholar 

  • Rose JE (1991) Transdermal nicotine and nasal nicotine administration as smoking cessation treatments. In: Cocores JA (ed) The clinical management of nicotine dependence. Springer, Berlin Heidelberg New York, pp 196–207

    Google Scholar 

  • Rose JE, Behm FM (1987) Refined cigarette smoke as a method for reducing nicotine intake. Pharmacol Biochem Behav 28: 305–310

    PubMed  CAS  Google Scholar 

  • Rose JE, Levin ED (1991) Concurrent agonist-antagonist administration for the analysis and treatment of drug dependence. Pharmacol Biochem Behav 41: 219–226

    Google Scholar 

  • Rose JE, Sampson A, Levin ED, Henningfield JE (1989) Mecamylamine increases nicotine preference and attenuates nicotine discrimination. Pharmacol Biochem Behav 32: 933–938

    PubMed  CAS  Google Scholar 

  • Rose JE, Behm FM, Westman EC, Levin ED, Stein RM, Ripka GV (1994) Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone. Clin Pharnacol 56: 86–99

    CAS  Google Scholar 

  • Russell MAH, Jarvis MJ, Sutherland G, Feyerabend C (1987a) Nicotine replacement in smoking cessation. JAMA 257: 3262–3265

    CAS  Google Scholar 

  • Russell MAH, Stapleton JA, Jackson PH, Hajek P, Belcher M (1987b) District programme to reduce smoking: effect of clinic supported brief intervention by general practitioners. Br Med J 295: 1240–1244

    CAS  Google Scholar 

  • Sachs DPL (1991) Advances is smoking cessation treatment. Curr Pulmonol 12: 139–198

    Google Scholar 

  • Sachs DPL, Leischow SJ (1991a) Pharmacological approaches to smoking cessation. Clin Chest Med 12: 9–10

    Google Scholar 

  • Sachs DPL, Leischow SJ (1991b) Dose-response effects of nicotine polacrilex. Am Rev Respit Dis 143: A255

    Google Scholar 

  • Sachs DPL, Bostrom AG, Hansen MD (1994) Relapse hazard functions during and after nicotine patch smoking cessation treatment. Abstract presented at the Society of Behavioral Medicine Meeting, Boston, April 1994

    Google Scholar 

  • Schacter S, Silverstein B, Kozlowski L, Perlick D, Hermann C, Liebling B (1977) Studies of the interaction of psychological and pharmacological determinants of smoking 106: 3–40

    Google Scholar 

  • Schneider NG, Jarvik ME (1984) Time course of smoking withdrawal symptoms as a function of nicotine replacement. Psychopharmacology 82: 143–144

    PubMed  CAS  Google Scholar 

  • Schneider NG, Jarvik ME, Forsythe AB, Read LL, Elliot ML, Schweiger A (1983) Nicotine gum in smoking cessation: a placebo-controlled double-blind trial. Addict Behav 10: 253–261

    Google Scholar 

  • Schuster CR, Lucchesi BR, Emley GS (1979) The effects of d-amphetamine, meprobamate and lobeline on the cigarette smoking behavior of normal human subjects. In: Krasnegor NA (ed) Cigarette smoking as a dependence process NIDA research monograph series 23 US Government Printing Office Washington DC, pp 91–99

    Google Scholar 

  • Schwartz JL (1987) Review and evaluation of smoking cessation methods: the United States and Canada. US Department of Health and Human Services Washington DC

    Google Scholar 

  • Schwartz JL, Dubitsky M (1968) One-year follow-up results of a smoking cessation program. Can J Publ Health 59: 161–165

    CAS  Google Scholar 

  • Sellers EM, Naranjo CA, Kadlec K (1987) Do serotonin uptake inhibitors decrease smoking? Observations in a group of heavy drinkers. J Clin Psychopharmacol 7: 417–420

    PubMed  CAS  Google Scholar 

  • Sepkovic DW, Colosimo SG, Axelrad CM, Adams JD, Haley NJ (1987) The delivery and uptake of nicotine from an aerosol rod. Am J Publ Health 76: 1343–1344

    Google Scholar 

  • Shiffman S (1993) Smoking cessation treatment: any progress? J Consult Clin psychol 61: 718–722

    PubMed  CAS  Google Scholar 

  • Shiffman SM (1979) The tobacco withdrawal syndrome. In: Krasnegor NA (ed) Cigarette smoking as a dependence process, NIDA research mongraph 23. US Department of Health and Human Services, Washington DC (HEW Publication no (ADM) 79–800 )

    Google Scholar 

  • Shiffman SM (1982) Relapse following smoking cessation: a situational analysis. J Consult Clin Psychol 50: 71–86

    PubMed  CAS  Google Scholar 

  • Silagy C, Mant D, Fowler G, Lodge M (1994a) Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 343: 139–142

    CAS  Google Scholar 

  • Silagy C, Mant D, Fowler G, Lodge M (1994b) The effectiveness of nicotine replacement therapies in smoking cessation. Curr Clin Trials 113

    Google Scholar 

  • Sobell LC, Sobell MB, Toneatto T (1992) Recovery from alcohol problems without treatment. In: Heather N, Miller WR, Greeley J (eds) Self-control and addictive behaviors. MacMallion, Sidney, pp 198–242

    Google Scholar 

  • Spring B, Wurtman J, Gleason R, Wurtman R, Kessler K (1991) Weight gain and withdrawal symptoms after smoking cessation: a preventive intervention using d-fenfluramine. Health Psychol 10: 216–223

    PubMed  CAS  Google Scholar 

  • Stolerman IP (1986) Could nicotine antagonists be used in smoking cessation. Br J Addict 81: 47–53

    PubMed  CAS  Google Scholar 

  • Sutherland G, Russell MAH, Stapleton J, Feyerabend C, Ferno O (1992a) Nasal nicotine spray: a rapid nicotine delivery system. Psychopharmacology 108: 512–518

    CAS  Google Scholar 

  • Sutherland G, Stapleton JA, Russell MAH, Jarvis MJ, Hajek P, Belcher M, Feyerabend C (1992b) Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet 340: 324–329

    CAS  Google Scholar 

  • Tan JL, Law M, Wald N (1994) How effective is nicotine replacement therapy in helping people to stop smoking? Br Med J 308: 21–25

    Google Scholar 

  • Targovnik JH (1989) Nicotine, corticotropin, and smoking withdrawal symptoms: literature review and implications for successful control of nicotine addiction. Clin Ther 11: 846–853

    PubMed  CAS  Google Scholar 

  • Tennant FS, Tarver AL (1985) Withdrawal from nicotine dependence using mecamylamine: comparison of three-week and six-week dosage schedules. In: Harris LS (ed) Problems of drug dependence, 1984, US Government Printing Office, Washington DC, pp 291–297 (NIDA research monograph series 55 )

    Google Scholar 

  • Tennant FS, Tarver AL, Rawson RA (1984) Clinical evaluation of mecamylamine for withdrawal from nicotine dependence. In: Harris LS (ed) Problems of drug dependence. US Government Printing Office, Washington DC (NIDA research monograph 49 )

    Google Scholar 

  • Tonnesen P, Fryd V, Hansen M, Helsted J, Gunnersen A, Forchammer H, Stockner M (1988) Effect of nicotine chewing gum in combination with group counseling in the cessation of smoking. N Engl J Med 318: 15–27

    PubMed  CAS  Google Scholar 

  • Tonnesen P, Norregaard J, Mikkelsen K, Jorgensen S, Nilsson F (1993) A double-blind trial of a nicotine inhaler for smoking cessation. JAMA 269: 1268–1271

    PubMed  CAS  Google Scholar 

  • Transdermal Nicotine Study Group (1991) Transdermal nicotine for smoking cessation: results of two multicenter controlled trials. JAMA 266: 3133–3138

    Google Scholar 

  • US Department of Health and Human Services (1988) Tobacco use compared to other drug dependencies. The health consequences of smoking: nicotine addition: a report of the US Surgeon General, US Government Printing Office, Washington DC, pp 241–375

    Google Scholar 

  • Viswesvaran C, Schmidt FL (1992) A meta-analytic comparison of the effectiveness of smoking cessation methods. J Appl Psychol 77: 554–561

    PubMed  CAS  Google Scholar 

  • Volpicelli JR, Alterman AI, Hayashida M, O’Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49: 876–880

    PubMed  CAS  Google Scholar 

  • Wei H, Young D (1988) Effect of clonidine on cigarette cessation and in the alleviation of withdrawal symptoms. Br J Addict 83: 1221–1227

    PubMed  Google Scholar 

  • Wender PH, Reimherr FW, Wood D et al. (1985) A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type in adults. Am J Psychiatry 142: 547–552

    PubMed  CAS  Google Scholar 

  • West RJ (1985) Corticotrophin injections to treat cigarette withdrawal symptoms. J R Soc Med 78: 1065–1066

    PubMed  CAS  Google Scholar 

  • West RJ, Hajek P, Burrows S (1990) Effect of glucose tablets on craving for cigarettes. Psychopharmacology 101: 555–559

    PubMed  CAS  Google Scholar 

  • West RJ, Hajek P, NcNeill A (1991) Effect of buspirone on cigarette withdrawal symptoms and short-term abstinence rates in a smokers clinic. Psychopharmacology 104: 91–96

    PubMed  CAS  Google Scholar 

  • Wetter DW, Fiore MC, Young TB, Baker TB (in press) Nicotine withdrawal and nicotine replacement influence objective measures of sleep. J Consult Clin Psychol (in press)

    Google Scholar 

  • Zikos A, Molter G, Romovacek M, Nellis K, Gaudio R (1991) Comparison of nicotine gum, clonidine and no medication in a multidisciplinary smoking cessation program. Chest 100:3S

    Google Scholar 

Download references

Authors
  1. J. R. Hughes
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University Psychiatric Center, Wayne State University School of Medicine, 2751 E. Jefferson Avenue, 48207, Detroit, MI, USA

    Charles R. Schuster Ph.D.

  2. Director, The National Institute on Drug Abuse, Addiction Research Center, P.O. Box 5180, 21224, Baltimore, MD, USA

    Michael J. Kuhar Ph.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hughes, J.R. (1996). Pharmacotherapy of Nicotine Dependence. In: Schuster, C.R., Kuhar, M.J. (eds) Pharmacological Aspects of Drug Dependence. Handbook of Experimental Pharmacology, vol 118. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60963-3_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60963-3_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64631-7

  • Online ISBN: 978-3-642-60963-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation